[1]
Bjørnhart, B. et al. 2023. 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy. Acta Oncologica. 62, 8 (Aug. 2023), 861–870. DOI:https://doi.org/10.1080/0284186X.2023.2238544.